Opinion|Videos|January 29, 2025
Assessing Treatment Efficacy: Communication with Patients and Caregivers
Author(s)Jose De La Cerda III, MD, MPH
This video segment covers patient selection criteria for different versions of abiraterone, strategies for assessing treatment efficacy and safety, engaging caregivers to monitor compliance and side effects, and navigating insurance challenges to ensure patients receive the recommended version.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How do you assess abiraterone efficacy and safety once the treatment is started? What questions should one ask patients?
- How often do you engage caregivers and ask about patient’s treatment compliance or experience with side effects?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC
5
